PTEN deficiency sensitizes endometrioid endometrial cancer to compound PARP-PI3K inhibition but not PARP inhibition as monotherapy.
about
PTEN deficiency sensitizes endometrioid endometrial cancer to compound PARP-PI3K inhibition but not PARP inhibition as monotherapy.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
PTEN deficiency sensitizes end ...... ARP inhibition as monotherapy.
@en
PTEN deficiency sensitizes end ...... ARP inhibition as monotherapy.
@nl
type
label
PTEN deficiency sensitizes end ...... ARP inhibition as monotherapy.
@en
PTEN deficiency sensitizes end ...... ARP inhibition as monotherapy.
@nl
prefLabel
PTEN deficiency sensitizes end ...... ARP inhibition as monotherapy.
@en
PTEN deficiency sensitizes end ...... ARP inhibition as monotherapy.
@nl
P2093
P2860
P356
P1433
P1476
PTEN deficiency sensitizes end ...... ARP inhibition as monotherapy.
@en
P2093
T M Roberts
P2860
P2888
P304
P356
10.1038/ONC.2017.326
P407
P577
2017-09-25T00:00:00Z